On the recordMarch 21, 2017
The OPEN Act has the potential to result in hundreds of new drugs and treatments for individuals with rare diseases.
Source
congress.govEditor's note · Context
Bilirakis highlights the potential impact of the OPEN Act on drug availability for rare diseases.
Share & report
More from Gus Bilirakis
Apr 28, 2025
Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and insert extraneous material in the Record for this particular bill. The SPEAKER pro tempore. Is there…
Apr 28, 2025
Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material in the Record on this particular bill. The SPEAKER pro tempore. Is there…
Apr 28, 2025
Mr. Speaker, in closing, I encourage a ``yes'' vote on this particular bill. Again, I commend Representatives Trahan and Carey. I yield back the balance of my time.
Apr 28, 2025
Mr. Speaker, I yield such time as he may consume to the gentleman from Ohio (Mr. Latta), the chairman of the Energy Committee and my good friend, a legislative machine in my opinion.
Other voices in this conversation
